Hostname: page-component-89b8bd64d-mmrw7 Total loading time: 0 Render date: 2026-05-09T12:15:57.792Z Has data issue: false hasContentIssue false

Four years of the COVID-19 pandemic: how does Brazil deal with the impacts? A DOHaD perspective

Published online by Cambridge University Press:  23 September 2024

Ariana Musa de Aquino
Affiliation:
Laboratory of Endocrine Disruptors and Carcinogens, Institute of Biosciences of Botucatu, Sao Paulo State University (UNESP), Botucatu, São Paulo, Brazil
Larissa Lopes da Cruz
Affiliation:
Laboratory of System Physiology and Reproductive Toxicology, Institute of Biological and Health Sciences, Federal University of Mato Grosso (UFMT), Barra do Garças, Mato Grosso, Brazil
Henrique José Cavalcanti Bezerra Gouveia
Affiliation:
Studies in Nutrition and Phenotypic Plasticity Unit, Center for Health Sciences, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
Márcia Maria da Silva
Affiliation:
Studies in Nutrition and Phenotypic Plasticity Unit, Center for Health Sciences, Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
Maysa Rocha de Souza
Affiliation:
Laboratory of Experimental Research on Gynecology and Obstetrics, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil
Mayara da Nóbrega Baqueiro
Affiliation:
Laboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil
Isabelle Tenori Ribeiro
Affiliation:
Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University (UNESP), Botucatu, São Paulo, Brazil
Emanuelle Vasconcellos de Lima
Affiliation:
Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
Pedro Vinicius Gonçalves Martins
Affiliation:
Laboratory of Endocrine Physiology, Institute of Biology Roberto Alcantara Gomes, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil
Carolina Oliveira Gonçalves
Affiliation:
Laboratory of Vascular Pharmacology, Center of Biological Sciences, State University of Londrina (UEL), Londrina, Paraná, Brazil
Graziela Scalianti Ceravolo
Affiliation:
Laboratory of Vascular Pharmacology, Center of Biological Sciences, State University of Londrina (UEL), Londrina, Paraná, Brazil
Rosiane Aparecida Miranda*
Affiliation:
Laboratory of Endocrine Physiology, Institute of Biology Roberto Alcantara Gomes, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil
*
Corresponding author: R. A. Miranda; Emails: roapmiranda@yahoo.com.br; miranda.rosiane@uerj.br
Rights & Permissions [Opens in a new window]

Abstract

Over the last few years, during the pandemic, the Brazilian population has suffered several problems, ranging from health to socioeconomic impacts. When we consider Brazilian science, there has been an undeniable scientific delay generated by the pandemic, especially in areas that are not related to the coronavirus. In this context, with the aim of fostering collaboration among researchers in the field of Developmental Origins of Health and Diseases (DOHaD) and enhancing the potential for implementing public health strategies to prevent noncommunicable chronic diseases, the Brazilian Association of Developmental Origins of Health and Diseases (DOHaD Brazil) was established in 2020. In this narrative, we explore the effects of the COVID-19 pandemic in Brazil, focusing on its impacts on scientific research conducted in universities. Additionally, we underscore the significance of the DOHaD Brazil Association, particularly from the perspective of young researchers engaged in DOHaD research in Brazil.

Information

Type
Editorial
Copyright
© The Author(s), 2024. Published by Cambridge University Press in association with The International Society for Developmental Origins of Health and Disease (DOHaD)